Risultati di ricerca
The 2002 United States Senate election in Iowa was held on November 5, 2002. Incumbent Democratic U.S. Senator Tom Harkin sought re-election to a fourth term in office. Harkin was opposed in the general election by U.S. Congressman Greg Ganske, who fought off a difficult challenger in the Republican primary. Though Harkin narrowly defeated his ...
Thomas I. Barkin (born 1961) is an American central banker, who became the eighth president and CEO of the Federal Reserve Bank of Richmond on January 1, 2018. He worked at global management consulting firm McKinsey & Company for 30 years in increasingly senior positions, including as global chief financial officer (CFO) and chief risk officer, with oversight of finance, legal and information ...
About Tom. Tom Harkin is a product of small town Iowa who has not forgotten his origins. He was born November 19, 1939 to a coal miner father and a Slovenian immigrant mother who passed away when Tom was ten years old. Tom, his three brothers and two sisters and their parents shared a two-bedroom home in Cumming, Iowa (population 150).
Tom Harkin is a product of small town Iowa who has not forgotten his origins. He was born November 19, 1939 to a coal miner father and a Slovenian immigrant mother who passed away when Tom was ten years old. Tom, his three brothers and two sisters and their parents shared a two-bedroom home in Cumming, Iowa (population 150).
The 2008 United States Senate election in Iowa was held on November 4, 2008. Incumbent Senator Tom Harkin sought re-election to a fifth term in office. Unlike Harkin's three previous reelection bids, he was not challenged by a sitting United States Congressman but instead faced small businessman Christopher Reed, who won the Republican primary by just a few hundred votes.
トーマス・リチャード「トム」・ハーキン（Thomas Richard "Tom" Harkin, 1939年 11月19日 - ）は、アメリカ合衆国の政治家。民主党所属。1985年から2015年までアイオワ州選出の連邦上院議員を務めた。その間、上院の農業委員長を何度も務めている。
After Harkin appeared on television in 1994 with cancer patients who blamed Jacobs for blocking their access to antineoplastons, Jacobs resigned from the OAM in frustration. In an interview with Science , Jacobs criticized Harkin and other politicians for pressuring his office, promoting certain therapies, and, he says, attempting an end-run around objective science."
